AR087539A1 - ELECTROLYTIC FORMULATION READY FOR USE, BAG READY FOR USE, KIT, USES AND RENAL INSUFFICIENCY TREATMENT METHOD - Google Patents
ELECTROLYTIC FORMULATION READY FOR USE, BAG READY FOR USE, KIT, USES AND RENAL INSUFFICIENCY TREATMENT METHODInfo
- Publication number
- AR087539A1 AR087539A1 ARP120102980A ARP120102980A AR087539A1 AR 087539 A1 AR087539 A1 AR 087539A1 AR P120102980 A ARP120102980 A AR P120102980A AR P120102980 A ARP120102980 A AR P120102980A AR 087539 A1 AR087539 A1 AR 087539A1
- Authority
- AR
- Argentina
- Prior art keywords
- ready
- kit
- bag
- treatment method
- electrolytic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
Abstract
Reivindicación 1: Formulación electrolítica lista para su uso, caracterizada por contener sulfato de magnesio, por lo menos otro electrolito y vehículos apropiados. Reivindicación 3: Formulación electrolítica lista para su uso, de acuerdo con la reivindicación 1, caracterizada por el hecho de que dicho otro electrolito es seleccionado entre cloruro de sodio, cloruro de potasio, cloruro de calcio, cloruro de magnesio, acetatos, carbonatos, fosfatos y bicarbonatos. Reivindicación 4: Formulación electrolítica lista para su uso, de acuerdo con la reivindicación 1, caracterizada por el hecho de que dicho vehículo es agua. Reivindicación 11: Bolsa lista para su uso, de acuerdo con la reivindicación 9, caracterizada por el hecho de estar constituida de un material seleccionado de polipropileno (PP), cloruro de polivinilo (PVC), copolímeros de etileno-acetato de vinilo (EVA), diclorhidrato de polivinilo, y lo similar.Claim 1: Ready-to-use electrolytic formulation, characterized in that it contains magnesium sulfate, at least one other electrolyte and appropriate vehicles. Claim 3: Electrolytic formulation ready for use, according to claim 1, characterized in that said other electrolyte is selected from sodium chloride, potassium chloride, calcium chloride, magnesium chloride, acetates, carbonates, phosphates and bicarbonates. Claim 4: Electrolytic formulation ready for use, according to claim 1, characterized in that said vehicle is water. Claim 11: Bag ready for use, according to claim 9, characterized in that it consists of a material selected from polypropylene (PP), polyvinyl chloride (PVC), ethylene-vinyl acetate (EVA) copolymers , polyvinyl dihydrochloride, and the like.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI1104153-6A BRPI1104153A2 (en) | 2011-08-25 | 2011-08-25 | Ready-to-use electrolyte formulation, ready-to-use pouch, kit, uses and method of treating renal failure |
Publications (1)
Publication Number | Publication Date |
---|---|
AR087539A1 true AR087539A1 (en) | 2014-04-03 |
Family
ID=47745788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120102980A AR087539A1 (en) | 2011-08-25 | 2012-08-14 | ELECTROLYTIC FORMULATION READY FOR USE, BAG READY FOR USE, KIT, USES AND RENAL INSUFFICIENCY TREATMENT METHOD |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR087539A1 (en) |
BR (1) | BRPI1104153A2 (en) |
UY (1) | UY34288A (en) |
WO (1) | WO2013026118A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8105258B2 (en) * | 1999-04-26 | 2012-01-31 | Baxter International Inc. | Citrate anticoagulation system for extracorporeal blood treatments |
DE102004023828A1 (en) * | 2004-05-13 | 2005-12-08 | Fresenius Medical Care Deutschland Gmbh | Solution for peritoneal dialysis |
BRPI0603854A (en) * | 2006-08-30 | 2007-04-17 | Sociedade Benef Israelita Bras | solution for replacement of lost electrolytes during dialysis procedure in patients with acute kidney disease |
BRPI0603844A (en) * | 2006-08-30 | 2007-04-17 | Sociedade Benef Israelita Bras | diallytic solution applied to patients with acute kidney disease |
CN101912414A (en) * | 2010-08-20 | 2010-12-15 | 宋青 | Blood purification base displacing liquid |
-
2011
- 2011-08-25 BR BRPI1104153-6A patent/BRPI1104153A2/en not_active IP Right Cessation
-
2012
- 2012-08-14 AR ARP120102980A patent/AR087539A1/en unknown
- 2012-08-16 WO PCT/BR2012/000298 patent/WO2013026118A1/en active Application Filing
- 2012-08-23 UY UY0001034288A patent/UY34288A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI1104153A2 (en) | 2015-08-25 |
UY34288A (en) | 2013-04-05 |
WO2013026118A1 (en) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20156421B (en) | Insert for vapor-permeable and waterproof soles | |
EP4056283A3 (en) | Collector for mineral flotation and use therof | |
WO2014151718A3 (en) | Water-soluble film for delayed release | |
GB201211995D0 (en) | De-icer and/or anti-icer compostions and methods | |
UA106767C2 (en) | An insert for water-proof and vapor-permeable shoes | |
WO2014031852A3 (en) | Blood storage container containing aqueous composition for the storage of red blood cells | |
GB2473447B (en) | Tile and tile holding device | |
BR112015012008A2 (en) | shark barrier | |
EA201291170A1 (en) | SPECIFIC SYSTEMS WITH LOW CONTENTS OF SURFACE-ACTIVE SUBSTANCES OF SOFT ACTION, WITH HIGH CONTENTS OF RELAXING MEANS, WHICH REMAIN THE FOAMING AND THE PHASE OF THIS | |
BR112016018360A2 (en) | REACTIVE COMPOSITION, PROCESSES FOR PRODUCING A COMPOSITION AND FOR PURIFICATION OF A FLUE GAS, AND USE OF A COMPOUND | |
EA200801606A1 (en) | PRELIMINARY MOISTENED ANTICOLANT COMPOSITION WITH STABILIZED SATURATION | |
AR060264A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING LACTATE AND CALCIUM, USES OF SUCH COMPOSITION AND PREPARATION METHOD | |
MX2018007112A (en) | Fast dissolving peroxymonosulfate composition. | |
MX336387B (en) | Anhydrous antiperspirant compositions. | |
AR102441A1 (en) | FOOD CONCENTRATE | |
AR087539A1 (en) | ELECTROLYTIC FORMULATION READY FOR USE, BAG READY FOR USE, KIT, USES AND RENAL INSUFFICIENCY TREATMENT METHOD | |
EA201791670A1 (en) | HARD COMPOSITIONS FOR CARE OF THE ORAL CAVITY | |
PE20151085A1 (en) | COMPOSITION OF XANTOFILAS | |
CL2012000371A1 (en) | Composition capable of swelling in salt water comprising a smectite clay, acrylamide copolymer, elastomeric resin, cationic flocculant and primary plasticizer for the elastomeric resin; method of waterproofing a surface; sealed concrete structure; and a saltwater barrier article. | |
EP3023639A3 (en) | System for water supply using sunlight | |
SV2006002223A (en) | PHARMACEUTICAL COMPOSITION REF. BHCO41369-SV | |
PE20141366A1 (en) | CONTROLLED RELEASE SYSTEM AND USES OF THE SAME | |
EP3593650A3 (en) | Preparations capable of increasing the ph of food by releasing molecular hydrogen | |
RU2009126331A (en) | CRYSTALLOID CARDIOPLEGIC SOLUTION | |
PE20151432A1 (en) | SUSTAINED RELEASE LORAZEPAM FORMULATIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |